Superior therapy response predictions for patients with glioblastoma (GBM) using Cellworks Singula: MyCare-009-03.

2519Background: Despite using cytogenetic and molecular-risk stratification and precision medicine, the current overall outcome of GBM patients remains relatively poor. Therapy selection is often b...